21 CFR 870.2215 — Predictive Indicator For Long-Term Cardiovascular Outcomes

Cardiovascular (CV) · Part 870 Subpart C—Cardiovascular Monitoring Devices · § 870.2215

Identification

CaRi-Heart is a software device used to produce analysis results to assist Healthcare Professionals in patient management. It helps operators assess vascular inflammation from coronary computed tomography angiography (CCTA) images and measure risk of cardiovascular mortality due to coronary inflammation and other clinical risk factors. It is indicated for adults from 30 to 80 years old who have been referred for CCTA imaging.

Classification Rationale

FDA concludes that this device should be classified into Class II. This order classifies the device into Class II under the generic name predictive indicator for long-term cardiovascular outcomes, with the establishment of special controls to provide reasonable assurance of the safety and effectiveness of the device type.

Product Codes

Product CodeDevice NameClassDevicesAttributes
SIUPredictive Indicator For Long-Term Cardiovascular Outcomes21SaMD
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...